Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. M.J. (Maarten) Postma

prof. dr. M.J. (Maarten) Postma

Hoogleraar Global Health Economics UMCG & RUG (Medische en Economie & Bedrijfskunde faculteiten)
Profielfoto van prof. dr. M.J. (Maarten) Postma
Telefoon:
050 361 5084 (secretariaat)
E-mail:
m.j.postma rug.nl

Publicaties

Accuracy of the Modified Finnish Diabetes Risk Score (Modified FINDRISC) for detecting metabolic syndrome: Findings from the Indonesian national health survey

A Comprehensive View of the Methods Used to Measure the Societal Impact of Healthcare Interventions: A Systematic Review

A cost-minimization analysis of anti-VEGFs for the treatment of neovascular age-related macular degeneration in the Netherlands

Changing life expectancy in European countries 1990–2021: A subanalysis of causes and risk factors from the Global Burden of Disease Study 2021

Characterising acute and chronic care needs: Insights from the Global Burden of Disease Study 2019

Controlling the COVID-19 pandemic through vaccination: a perspective from Indonesia

Correction to: Cost-effectiveness of finerenone in chronic kidney disease associated with type 2 diabetes in The Netherlands (Cardiovascular Diabetology, (2023), 22, 1, (328), 10.1186/s12933-023-02053-6)

Cost-effectiveness Analysis of COVID-19 mRNA XBB.1.5 Fall 2023 Vaccination in the Netherlands

Cost-Effectiveness Analysis of Mammography-Based Breast Cancer Screening in Indonesia

Cost-Effectiveness Analysis of Nirsevimab for Preventing Respiratory Syncytial Virus-Related Lower Respiratory Tract Disease in Dutch Infants: An Analysis Including All-Infant Protection

Pers/media

Maarten Postma: Cost-effectiveness is stick for Big Pharma

The Office of Health Economics

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-